Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease
- PMID: 11696568
- PMCID: PMC209448
- DOI: 10.1172/JCI14273
Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease
Figures

Comment on
-
The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium.J Clin Invest. 2001 Nov;108(9):1307-14. doi: 10.1172/JCI12877. J Clin Invest. 2001. PMID: 11696575 Free PMC article.
References
-
- Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217–242. - PubMed
-
- Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol. 2000;86:3–8. - PubMed
-
- Rollins, B. 2000. MCP-1, -2, -3, -4, -5. In Cytokine reference. J. Oppenheim et al., editors. Academic Press. London, United Kingdom. 1145–1160.
-
- Gu L, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275–281. - PubMed
-
- Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2–/– mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894–897. - PubMed